ConductScience.org, home

Trial · NCT05543174

Results by group18

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change in Fasting Serum Bile Acid (sBA) Levels From Week 18 to Week 22TAK-62517.64395% Confidence Interval -31.6389 to 66.9246micromoles per liter (mcmol/L)
Change in Fasting sBA Levels From Baseline to Week 18TAK-6258.30095% Confidence Interval -37.4110 to 54.0110mcmol/L
Change in Weekly Average Severity of Pruritus Measured by Itch Reported Outcome (ItchRO) (Observer Instrument [Obs]) From Baseline to Week 18TAK-625-1.53195% Confidence Interval -2.3405 to -0.7208score on a scale
Change in Weekly Average Morning Severity of Pruritus Measured by Itch Reported Outcome (ItchRO) (Observer Instrument [Obs]) From Baseline to Week 18TAK-625-1.32795% Confidence Interval -2.1071 to -0.5460score on a scale
Change in Weekly Average Severity of Pruritus Measured by ItchRO (Obs) From Week 18 to Week 22TAK-625-0.28695% Confidence Interval -0.6594 to 0.0880score on a scale
Change in Weekly Average Morning Severity of Pruritus Measured by ItchRO (Obs) From Week 18 to Week 22TAK-625-0.28095% Confidence Interval -0.6769 to 0.1163score on a scale
Change in Weekly Average Severity of Pruritus Measured by ItchRO (Pt) From Baseline to Week 18TAK-625-1.38195% Confidence Interval -5.0058 to 2.2439score on a scale
Change in Weekly Average Morning Severity of Pruritus Measured by ItchRO (Pt) From Baseline to Week 18TAK-625-1.23895% Confidence Interval -3.6537 to 1.1775score on a scale
Change in Alanine Aminotransferase (ALT) and Alkaline Phosphatase (ALP) Levels From Baseline to Week 18TAK-625Change in ALT17.795% Confidence Interval -52.66 to 88.09Units per liter (U/L)
Change in Alanine Aminotransferase (ALT) and Alkaline Phosphatase (ALP) Levels From Baseline to Week 18TAK-625Change in ALP75.695% Confidence Interval -186.50 to 337.64Units per liter (U/L)
Change in Bilirubin (Total and Direct) Levels From Baseline to Week 18TAK-625Change in total bilirubin11.361995% Confidence Interval -20.13472 to 42.85861mcmol/L
Change in Bilirubin (Total and Direct) Levels From Baseline to Week 18TAK-625Change in direct bilirubin8.600995% Confidence Interval -15.59872 to 32.80046mcmol/L
Change in Weekly Average Severity of Pruritus Measured by ItchRO (Pt) From Week 18 to Week 22TAK-6250.00095% Confidence Interval -0.6147 to 0.6147score on a scale
Change in Weekly Average Morning Severity of Pruritus Measured by ItchRO (Pt) From Week 18 to Week 22TAK-625-0.03295% Confidence Interval -0.4120 to 0.3485score on a scale
Change in ALT and ALP Levels From Week 18 to 22TAK-625Change in ALT7.995% Confidence Interval -22.18 to 37.89U/L
Change in ALT and ALP Levels From Week 18 to 22TAK-625Change in ALP-32.395% Confidence Interval -79.12 to 14.55U/L
Change in Bilirubin (Total and Direct) Levels From Week 18 to 22TAK-625Change in total bilirubin0.684295% Confidence Interval -4.60580 to 5.97412mcmol/L
Change in Bilirubin (Total and Direct) Levels From Week 18 to 22TAK-625Change in direct bilirubin1.221795% Confidence Interval -1.83803 to 4.28146mcmol/L

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05543174/results